Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB known ✓ | P10828 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 4/20 | 0.57 |
| ▸ | CES2 | O00748 | 3/20 | 0.43 |
| ▸ | CES1 | P23141 | 3/20 | 0.43 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7704836 | 1.00 | TSHR (0.57) | TSHRTHRBCES2CES1DNM1 | |
| SCHEMBL10364806 | 1.00 | — | — | |
| SCHEMBL29880995 | 1.00 | TSHR (0.57) | TSHRTHRBCES2CES1DNM1 | |
| SCHEMBL7744361 | 1.00 | — | — | |
| SCHEMBL10757626 | 1.00 | TSHR (0.57) | TSHRTHRBCES2CES1DNM1 | |
| SCHEMBL29558624 | 1.00 | TSHR (0.57) | TSHRTHRBCES2CES1DNM1 | |
| SCHEMBL11353224 | 1.00 | TSHR (0.57) | TSHRTHRBCES2CES1DNM1 | |
| SCHEMBL9328424 | 1.00 | TSHR (0.57) | TSHRTHRBCES2CES1DNM1 | |
| SCHEMBL7738518 | 0.96 | — | — | |
| SCHEMBL29407263 | 0.96 | TSHR (0.50) | TSHRTHRBCES2CES1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4127119-B1 | WATER-GLYCOL HYDRAULIC FLUID | SHELL INT RESEARCH (NL) | 2025-08-27 | — | — | EP | claimed |
| US-5980947-A | MIXING SOLVENT CONTAINING A MIXTURE OF AT LEAST ONE WATER INSOLUBLE SOLVENT AND AT LEAST ONE WATER-MISCIBLE SOLVENT WITH A FATTY ACID OR A PHARMACOLOGICALLY ACCEPTABLE SALT TO FORM OIL PHASE; SUSTAIN RELEASING PEPTIDE OR ANTITUMOR AGENTAGENT | EISAI CO., LTD. (JP) | 1999-11-09 | — | — | US | claimed |
| EP-0461630-B1 | Production process of microspheres | EISAI CO LTD (JP) | 1995-09-13 | — | — | EP | claimed |
| EP-0461630-A2 | Production process of microspheres | Eisai Co., Ltd. (JP) | 1991-12-18 | — | — | EP | claimed |
| US-12578296-B2 | Bio-electrode, and method for manufacturing the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-03-17 | — | — | US | disclosed |
| US-20250352110-A1 | BIO-ELECTRODE COMPOSITION, BIO-ELECTRODE, AND METHOD FOR PRODUCING BIO-ELECTRODE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-11-20 | — | — | US | disclosed |
| EP-4492406-B1 | BIO-ELECTRODE COMPOSITION, BIO-ELECTRODE, METHOD FOR MANUFACTURING BIO-ELECTRODE | SHINETSU CHEMICAL CO (JP) | 2025-11-19 | — | — | EP | disclosed |
| EP-4651157-A1 | BIO-ELECTRODE COMPOSITION, BIO-ELECTRODE, AND METHOD FOR PRODUCING BIO-ELECTRODE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-11-19 | — | — | EP | disclosed |
| US-12453501-B2 | Bio-electrode composition, bio-electrode, method for manufacturing bio-electrode, and reaction composite | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-10-28 | — | — | US | disclosed |
| US-12419561-B2 | Bio-electrode composition, bio-electrode, and method for manufacturing bio-electrode | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-09-23 | — | — | US | disclosed |
| US-20250268501-A1 | BIO-ELECTRODE COMPOSITION, BIO-ELECTRODE, METHOD FOR MANUFACTURING BIO-ELECTRODE, POLYMER COMPOUND, AND COMPOSITE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-08-28 | — | — | US | disclosed |
| EP-4127119-B1 | WATER-GLYCOL HYDRAULIC FLUID | SHELL INT RESEARCH (NL) | 2025-08-27 | — | — | EP | disclosed |
| EP-3135727-A1 | POLYCARBONATE RESIN COMPOSITION | Teijin Limited (JP) | 2017-03-01 | — | — | EP | disclosed |
| US-20170037220-A1 | POLYCARBONATE RESIN COMPOSITION | TEIJIN LIMITED (JP) | 2017-02-09 | — | — | US | disclosed |
| US-6352808-B1 | Electrostatic-latent-image developing toner and inorganic particles used for such a toner | MINOLTA CO., LTD. (JP) | 2002-03-05 | — | — | US | disclosed |
| US-5980947-A | MIXING SOLVENT CONTAINING A MIXTURE OF AT LEAST ONE WATER INSOLUBLE SOLVENT AND AT LEAST ONE WATER-MISCIBLE SOLVENT WITH A FATTY ACID OR A PHARMACOLOGICALLY ACCEPTABLE SALT TO FORM OIL PHASE; SUSTAIN RELEASING PEPTIDE OR ANTITUMOR AGENTAGENT | EISAI CO., LTD. (JP) | 1999-11-09 | — | — | US | disclosed |
| EP-0461630-B1 | Production process of microspheres | EISAI CO LTD (JP) | 1995-09-13 | — | — | EP | disclosed |
| EP-0461630-A2 | Production process of microspheres | Eisai Co., Ltd. (JP) | 1991-12-18 | — | — | EP | disclosed |
| US-4838940-A | IMPARTED WITH AN ADHESIVENESS ON APPLICATION OF AN ELECTRIC CU RRENT | CANON KABUSHIKI KAISHA (JP) | 1989-06-13 | — | — | US | disclosed |
| EP-0280214-A2 | Image recording ink | CANON KABUSHIKI KAISHA (JP) | 1988-08-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12578296-B2 | Bio-electrode, and method for manufacturing the same | CUTA, CRY1, HCN3 | THRB 853/4885TSHR 499/4885CES2 2434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.